Skip to main content
. 2017 Oct 12;14:E95. doi: 10.5888/pcd14.170157

Table 1. Prevalence of Diabetic Retinopathya by Sociodemographic and Clinical Characteristics, and Means/Medians for Other Clinical Characteristics by Diabetic Retinopathya Status of Study Population in 3 Low-Income Municipalities, Mexico, 2014–2016.

Characteristics Total (N = 1,000) Has Diabetic Retinopathy, % (n = 317) Does Not Have Diabetic Retinopathy, % (n = 683) P Valueb
Overall 1,000 31.7 68.3
Sexc
Female 730 30.6 69.4 .20
Male 270 34.8 65.2
Socioeconomic statusc , d
Low 332 35.5 64.5 .04
Middle 332 32.8 67.2
High 331 26.6 73.4
Marital statusc
Single 100 20.0 80.0 .01
Married 675 31.6 68.4
Divorced 77 41.6 58.4
Widowed 133 35.3 64.7
Can speak an indigenous languagec
Yes 47 34.0 66.0 .71
No 949 31.5 68.5
Educationc
None 162 34.6 65.4 .06
Some elementary school 454 33.5 66.5
Some junior high school 237 32.9 67.1
Some high school 82 23.2 76.8
Some bachelor’s degree or more 63 19.1 80.9
Health system affiliationc
None 83 30.1 69.9 .26
IMSS 150 27.3 72.7
ISSSTE 72 23.6 76.4
Seguro Popular 681 33.5 66.5
Private 13 46.2 53.8
Other 1 0.0 100.0
Body mass index,c kg/m2
<25.0 247 44.9 55.1 <.001
25.0–29.9 416 30.8 69.2
≥30.0 321 23.1 76.9
Abdominal obesity (waist circumference ≥80 cm for women and ≥90 cm for men)c
Yes 869 30.4 69.6 .008
No 115 42.6 57.4
Triglycerides ≥150 mg/dLe
Yes 294 34.0 66.0 .32
No 124 29.0 70.1
Cholesterol ≥200 mg/dLe
Yes 168 37.5 62.5 .08
No 250 29.2 70.8
High-density lipoprotein cholesterol <50 mg/dL for women and <40 mg/dL for mene
Yes 329 31.3 68.7 .30
No 89 37.1 62.9
Insulin resistance HOMA index ≥3.8f
Yes 48 39.6 60.4 .004
No 64 15.6 84.4
High blood glucosec (fasting glucose ≥126 mg/dL or random glucose ≥200 mg/dL)
Yes 603 38.1 61.9 <.001
No 345 20.0 80.0
General hypertensionc (previous diagnosis or measurement of blood pressure ≥140/≥90 mm Hg)
Yes 524 35.5 64.5 .006
No 469 27.3 72.7
Physical activity used to control diabetesg , h
Yes 272 26.8 73.2 .01
No 554 35.6 64.4
Diet used to control diabetesg , h
Yes 345 30.4 69.6 .23
No 483 34.4 65.6
Age, mean (SD), yc 57.2 (11.0) 57.9 (9.3) 56.9 (11.7) .16
Time since diabetes diagnosis, median (IQR), yc 7.0 (3.0–14.0) 13.0 (8.0–18.0) 5.0 (2.0–10.0) <.001
Fasting capillary glucose, median (IQR), mg/dLi 149.0 (118.0–221.0) 194.5 (140.0–243.0) 137.0 (113.0–195.0) <.001
Random capillary glucose, median (IQR), mg/dLj 214.5 (155.0- 295.0) 240.0 (182.0–325.0) 196.0 (148.0–273.0) <.001
Fasting venous glucose, median (IQR), mg/dLk 153.0 (117.0–219.0) 198.0 (146.0–252.0) 135.5 (110.0–197.0) <.001
Insulin, median (IQR), µIU/mLf 9.75 (6.7–13.8) 10.4 (7.3–15.6) 9.5 (6.6–13.7) .48
Systolic blood pressure, median (IQR), mm Hgc 127.5 (115.5–142.0) 131.5 (118.5–147.5) 126.5 (114.0–140.0) <.001
Diastolic blood pressure, median (IQR), mm Hgc 72.0 (64.0–79.5) 72.5 (65.0–80.5) 71.5 (63.5–79.5) .19

Abbreviations: HOMA, homeostasis model assessment; IMSS, the Mexican Social Security Institute (Spanish: Instituto Mexicano del Seguro Social); IQR, interquartile range; ISSSTE, the Institute for Social Security and Services for State Workers (Spanish: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado).

a

Diabetic retinopathy classification according to Revised English Diabetic Eye Screening Program Grading System (grade 1, grade 2, or grade 3) (25).

b

χ2 test (contingency tables for more than 2 categories or proportion comparison), Student t test, or Mann–Whitney U test.

c

The percentage of participants with missing data was <5.0% or with complete information.

d

Socioeconomic index developed by using first principal component methodology.

e

Prevalence of diabetic retinopathy was 32.5% among those measured for triglycerides, total cholesterol, and high-density lipoprotein cholesterol (n = 418).

f

Prevalence of diabetic retinopathy was 25.9% among those measured for insulin (n = 112).

g

The percentage of participants with missing data ≥5.0%.

h

Determined by answer to question “Do you have any other treatment for sugar control?” Exercise (no/yes) and diet (yes/no) were provided as possible responses.

i

Prevalence of diabetic retinopathy was 30.7% among those measured for fasting capillary glucose (n = 423).

j

Prevalence of diabetic retinopathy was 31.6% among those measured for random capillary glucose (n = 402).

k

Prevalence of diabetic retinopathy was 32.5% among those measured for fasting venous glucose (n = 418).